Function
F2RL1 (Protease-activated receptor 2, PAR2) is a G protein-coupled receptor that binds trypsin and trypsin-like enzymes. Its activation triggers various signaling pathways, including phospholipase C (PLC), intracellular calcium, mitogen-activated protein kinase (MAPK), I-kappaB kinase/NF-kappaB, and Rho. It can also be activated by cleaved F2R/PAR1. PAR2 plays a crucial role in modulating inflammatory responses and regulating both innate and adaptive immunity. It acts as a sensor for proteolytic enzymes produced during infection, generally promoting inflammation. It can synergize with TLR4 and likely TLR2 in inflammatory responses, and modulates TLR3 signaling. PAR2 has a protective role in maintaining the endothelial barrier, which involves coagulation factor X. It regulates endothelial cell barrier integrity during neutrophil extravasation, likely following proteolytic cleavage by PRTN3. PAR2 has been proposed to have a bronchoprotective role in airway epithelium, but has also been shown to compromise the airway epithelial barrier by interrupting E-cadherin adhesion. PAR2 is involved in regulating vascular tone; activation results in hypotension, likely mediated by vasodilation. PAR2 associates with a subset of G protein alpha subunits, including GNAQ, GNA11, GNA14, GNA12, and GNA13, but not with G(o) alpha, G(i) subunit alpha-1, and G(i) subunit alpha-2. However, according to PubMed:21627585, it can signal through G(i) subunit alpha. PAR2 is believed to be a class B receptor that internalizes as a complex with arrestin and traffics with it to endosomal vesicles, presumably as a desensitized receptor, for extended periods of time. PAR2 mediates inhibition of TNF-alpha-stimulated JNK phosphorylation via coupling to GNAQ and GNA11; this function involves dissociation of RIPK1 and TRADD from TNFR1. PAR2 mediates phosphorylation of nuclear factor NF-kappa-B RELA subunit at 'Ser-536'; this function involves IKBKB and is predominantly independent of G proteins. PAR2 is involved in cellular migration, cytoskeletal rearrangement, and chemotaxis through beta-arrestin-promoted scaffolds, independent of GNAQ and GNA11. This function involves promotion of cofilin dephosphorylation and actin filament severing. PAR2 induces redistribution of COPS5 from the plasma membrane to the cytosol, and activation of the JNK cascade is mediated by COPS5. PAR2 participates in the recruitment of leukocytes to sites of inflammation and is the primary PAR receptor capable of modulating eosinophil function, including proinflammatory cytokine secretion, superoxide production, and degranulation. During inflammation, it promotes dendritic cell maturation, trafficking to the lymph nodes, and subsequent T-cell activation. PAR2 plays a role in the antimicrobial response of innate immune cells; activation enhances phagocytosis of Gram-positive bacteria and killing of Gram-negative bacteria. It synergizes with interferon-gamma to enhance antiviral responses. PAR2 has been implicated in a number of acute and chronic inflammatory diseases, such as those affecting the joints, lungs, brain, gastrointestinal tract, periodontium, skin, and vascular systems, as well as autoimmune disorders.